naproxen
FDA Approved
Description
Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) that reduces hormones causing inflammation and pain in the body. It is used to treat pain, inflammation, stiffness, and swelling associated with various musculoskeletal conditions. In congenital skeletal anomalies, it provides symptomatic relief from chronic pain and inflammation.
Indications & Therapeutic Use
pain, inflammation, arthritis, musculoskeletal pain, osteoarthritis
Linked Diseases:
Sprengel's deformity
Q74.0C535802
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
naproxen
| Generic Name | naproxen |
| Brands | 1 brand available |
| Active Ingredient | naproxen |
| Drug Class | pain |
| Manufacturer | Roche |
| Dosage Forms | oral tablet 250mg, 375mg, 500mg; oral suspension 125mg/5mL |
| Medical Code | M01AE02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 1 days |
| Reg. Status | FDA Approved |
| Countries | 10 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations11 Validated Nodes